Skip to main content
Contact Us
Subscribe
E-Edition
87°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Spruce Biosciences, Inc.
Spruce Biosciences Reports Second Quarter 2024 Financial Results and Provides Corporate Updates
August 12, 2024
From
Spruce Biosciences, Inc.
Via
Business Wire
Tickers
SPRB
Spruce Biosciences Recognized as a Bay Area Best Place to Work
June 06, 2024
From
Spruce Biosciences, Inc.
Via
Business Wire
Tickers
SPRB
Spruce Biosciences and HMNC Brain Health Announce Strategic Collaboration to Develop Treatment for Major Depressive Disorder (MDD)
June 04, 2024
From
Spruce Biosciences, Inc.
Via
Business Wire
Tickers
SPRB
Spruce Biosciences Presented Phase 2 POWER Study Results of Tildacerfont for the Treatment of Polycystic Ovary Syndrome at ENDO 2024
June 03, 2024
From
Spruce Biosciences, Inc.
Via
Business Wire
Tickers
SPRB
Spruce Biosciences to Participate in the Jefferies Global Healthcare Conference
May 23, 2024
From
Spruce Biosciences, Inc.
Via
Business Wire
Tickers
SPRB
Spruce Biosciences Announces Poster Presentations at the 2024 Annual Meeting of the Endocrine Society
May 22, 2024
From
Spruce Biosciences, Inc.
Via
Business Wire
Tickers
SPRB
Spruce Biosciences Reports First Quarter 2024 Financial Results and Provides Corporate Updates
May 13, 2024
From
Spruce Biosciences, Inc.
Via
Business Wire
Tickers
SPRB
Spruce Biosciences to Participate in May Investor Conferences
May 01, 2024
From
Spruce Biosciences, Inc.
Via
Business Wire
Tickers
SPRB
Spruce Biosciences Announces Additional Poster Presentation at the Pediatric Endocrine Society 2024 Annual Meeting
April 30, 2024
From
Spruce Biosciences, Inc.
Via
Business Wire
Tickers
SPRB
Spruce Biosciences Announces Upcoming Poster Presentation at the Pediatric Endocrine Society 2024 Annual Meeting
April 22, 2024
From
Spruce Biosciences, Inc.
Via
Business Wire
Tickers
SPRB
Spruce Biosciences Reports Full Year 2023 Financial Results and Provides Corporate Updates
March 13, 2024
From
Spruce Biosciences, Inc.
Via
Business Wire
Tickers
SPRB
Spruce Biosciences Announces Topline Results from CAHmelia-203 in Adult Classic CAH and CAHptain-205 in Pediatric Classic CAH
March 13, 2024
From
Spruce Biosciences, Inc.
Via
Business Wire
Tickers
SPRB
Spruce Biosciences to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
January 30, 2024
From
Spruce Biosciences, Inc.
Via
Business Wire
Tickers
SPRB
Spruce Biosciences Completes Enrollment in CAHmelia-204 Study for Adult Classic Congenital Adrenal Hyperplasia
January 22, 2024
From
Spruce Biosciences, Inc.
Via
Business Wire
Tickers
SPRB
Spruce Biosciences Reports Baseline Characteristics from CAHmelia-203 and CAHmelia-204 Studies in Adult Classic CAH
January 05, 2024
From
Spruce Biosciences, Inc.
Via
Business Wire
Tickers
SPRB
Spruce Biosciences Provides Clinical Program Updates and Outlook for 2024
January 04, 2024
From
Spruce Biosciences, Inc.
Via
Business Wire
Tickers
SPRB
Spruce Biosciences Reports Third Quarter 2023 Financial Results and Provides Corporate Updates
November 13, 2023
From
Spruce Biosciences, Inc.
Via
Business Wire
Tickers
SPRB
Spruce Biosciences to Participate in the Jefferies London Healthcare Conference
November 02, 2023
From
Spruce Biosciences, Inc.
Via
Business Wire
Tickers
SPRB
Spruce Biosciences Completes Target Enrollment of CAHmelia-203 Study in Adult Classic Congenital Adrenal Hyperplasia
October 18, 2023
From
Spruce Biosciences, Inc.
Via
Business Wire
Tickers
SPRB
Spruce Biosciences Reports Second Quarter 2023 Financial Results and Provides Corporate Updates
August 14, 2023
From
Spruce Biosciences, Inc.
Via
Business Wire
Tickers
SPRB
Spruce Biosciences Announces Acceptance of Abstract for Presentation at the Annual Meeting of the Endocrine Society (ENDO 2023)
June 12, 2023
From
Spruce Biosciences, Inc.
Via
Business Wire
Tickers
SPRB
Spruce Biosciences Appoints Percival Barretto-Ko to Board of Directors
May 25, 2023
From
Spruce Biosciences, Inc.
Via
Business Wire
Tickers
SPRB
Spruce Biosciences to Participate in the Jefferies Healthcare Conference
May 24, 2023
From
Spruce Biosciences, Inc.
Via
Business Wire
Tickers
SPRB
Spruce Biosciences Honored at CARES Foundation 15th Annual Everyone CARES Gala
May 22, 2023
From
Spruce Biosciences, Inc.
Via
Business Wire
Tickers
SPRB
Spruce Biosciences Reports First Quarter 2023 Financial Results and Provides Corporate Updates
May 15, 2023
From
Spruce Biosciences, Inc.
Via
Business Wire
Tickers
SPRB
Spruce Biosciences to Present Findings on Retrospective Analysis of Completion Rates for CAH Studies at Pediatric Endocrine Society 2023 Annual Meeting
May 04, 2023
From
Spruce Biosciences, Inc.
Via
Business Wire
Tickers
SPRB
Spruce Biosciences to Participate in May Investor Conferences
May 02, 2023
From
Spruce Biosciences, Inc.
Via
Business Wire
Tickers
SPRB
Spruce Biosciences Reports Full Year 2022 Financial Results and Provides Corporate Updates
March 16, 2023
From
Spruce Biosciences, Inc.
Via
Business Wire
Tickers
SPRB
Spruce Biosciences to Participate in the Oppenheimer 33rd Annual Healthcare Conference
February 28, 2023
From
Spruce Biosciences, Inc.
Via
Business Wire
Tickers
SPRB
Spruce Biosciences Announces $53.6 Million Private Placement Financing
February 09, 2023
From
Spruce Biosciences, Inc.
Via
Business Wire
Tickers
SPRB
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.